Trials / Conditions / MG
MG
4 registered clinical trials studyying MG — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens i NCT07294170 | argenx | — |
| Recruiting | ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Particip NCT07284420 | argenx | Phase 2 |
| Recruiting | Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Withdrawn | A Study of RD06-04 in Patients With Active Autoimmune Diseases NCT06548620 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |